AstraZeneca and its development ... with a history of asthma exacerbations and uncontrolled asthma receiving currently approved inhaled treatment versus placebo. The trial showed annual asthma ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been ... and research activities from: AstraZeneca, Boehringer Ingelheim ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

(MENAFN- EIN Presswire) Leading companies such as Novartis, Roche, Teva, and Merck are driving advancements in Severe Asthma treatments to enhance patient care. LAS VEGAS , NV, UNITED STATES ...